DurAVR™: Early safety and feasibility of a new class of biomimetic transcatheter aortic valve

^{Michael Reardon, MD

Houston Methodist
Houston, TX}

^{Chris Meduri, MD

Karolinska University Hospital
Solna, Sweden}

^{Rebecca Hahn, MD

Columbia University Irving Medical Center
New York, NY}

^{Azeem Latib, MD

Montefiore Medical Center
Bronx, NY}

This program was supported by:

DurAVR™: Early safety and feasibility of a new class of biomimetic transcatheter aortic valve

Conference

Country

First Name

Last Name

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Search TCTMD

DurAVR™: Early safety and feasibility of a new class of biomimetic transcatheter aortic valve